Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Elderly Patients With Acute Leukemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
Clinical Transplantation · 2025-08 · 39 (8)
DOI: 10.1111/ctr.70257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 24.07.2025. Verfasst von Wei Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University Peopl…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Transplantation, Haploidentical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
We explored the incidence, risk factors, and clinical characteristics of acute kidney injury (AKI) within 100 days posttransplantation, and its impact on the prognosis of haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) in elderly patients. A total of 224 elderly patients diagnosed with acute leukemia received haplo‐HSCT between January 1, 2019, and December 31, 2023 at Peking University People's Hospital. AKI affected 54.9% of the patients, with 33.5% in Stage 1, 18.3% in Stage 2, and 3.1% in Stage 3. Being female and having hypoalbuminemia were independent risk factors for developing severe AKI. Three‐year overall survival for AKI Stages 0, 1, 2, and 3 were 73.4%, 75.9%, 56.6%, and 14.3%, respectively ( p = 0.000). The 3‐year event‐free survival rates were 70.7%, 73.0%, 46.2%, and 0% ( p < 0.001). The 3‐year transplantation‐related mortality was 13.8% for Stages 0–1 and 48.1% for Stages 2–3 ( p < 0.001). Our study showed that more than half of elderly patients who underwent haplo‐HSCT developed AKI. Being female and having hypoalbuminemia before transplantation were at a significantly higher risk for severe AKI. Experiencing Stage 2 or more severe AKI was found to be an independent risk factor for increased mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, Chin…
- Peking University People's Hospital Medical Information Center, Beijing, China.
ORCID-Profile: Xiaodong Mo, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Yuqian Sun
Zitieren
APA
Sun, W., Lu, S., Wu, Y., Xu, Z., Ma, R., Mo, X., Wang, Y., Xu, L., Zhang, X., Huang, X., & Sun, Y. (2025). Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Elderly Patients With Acute Leukemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation. Clinical Transplantation, 39(8). https://doi.org/10.1111/ctr.70257
Vancouver
Sun W, Lu S, Wu Y, Xu Z, Ma R, Mo X, et al. Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Elderly Patients With Acute Leukemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 2025;39(8). doi:10.1111/ctr.70257
BibTeX
@article{Sun2025,
author = {Sun, Wei and Lu, Shengye and Wu, Yaqin and Xu, Zhengli and Ma, Rui and Mo, Xiaodong and Wang, Yu and Xu, Lanping and Zhang, Xiaohui and Huang, Xiaojun and Sun, Yuqian},
title = {Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Elderly Patients With Acute Leukemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {8},
doi = {10.1111/ctr.70257}
}
EUVIMED